These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 3609504)
1. Increased faecal glycosidases in patients with Crohn's disease. Ruseler-van Embden JG; van Lieshout LM Digestion; 1987; 37(1):43-50. PubMed ID: 3609504 [TBL] [Abstract][Full Text] [Related]
2. Induction in rats of serum agglutinins to Eubacterium, Peptostreptococcus and Coprococcus species by the faecal flora from patients with Crohn's disease and healthy subjects. Hazenberg MP; Van de Merwe JP; Custers-Van Lieshout LM; Pennock-Schröder AM J Hyg (Lond); 1984 Oct; 93(2):345-8. PubMed ID: 6501880 [TBL] [Abstract][Full Text] [Related]
3. Faecal mucus degrading glycosidases in ulcerative colitis and Crohn's disease. Rhodes JM; Gallimore R; Elias E; Allan RN; Kennedy JF Gut; 1985 Aug; 26(8):761-5. PubMed ID: 2991089 [TBL] [Abstract][Full Text] [Related]
4. Increased proteolysis and leucine aminopeptidase activity in faeces of patients with Crohn's disease. Ruseler-van Embden JG; van Lieshout LM Digestion; 1988; 40(1):33-40. PubMed ID: 3069527 [TBL] [Abstract][Full Text] [Related]
5. Anaerobic gram-negative faecal flora in patients with Crohn's disease and healthy subjects. Ruseler-van Embden JG; Both-Patoir HC Antonie Van Leeuwenhoek; 1983 Jun; 49(2):125-32. PubMed ID: 6614898 [TBL] [Abstract][Full Text] [Related]
6. The faecal flora of patients with Crohn's disease. Wensinck F; Custers-van Lieshout ; Poppelaars-Kustermans PA; Schröder AM J Hyg (Lond); 1981 Aug; 87(1):1-12. PubMed ID: 7019315 [TBL] [Abstract][Full Text] [Related]
7. Agglutination of Eubacterium and Peptostreptococcus species as a diagnostic test for Crohn's disease. van de Merwe JP Hepatogastroenterology; 1981 Jun; 28(3):155-6. PubMed ID: 7250896 [TBL] [Abstract][Full Text] [Related]
8. Induction of chronic arthritis in rats by cell wall fragments of anaerobic coccoid rods isolated from the faecal flora of patients with Crohn's disease. Severijnen AJ; Hazenberg MP; van de Merwe JP Digestion; 1988; 39(2):118-25. PubMed ID: 3410168 [TBL] [Abstract][Full Text] [Related]
9. A possible role of Eubacterium and Peptostreptococcus species in the aetiology of Crohn's disease. van de Merwe JP; Mol GJ Antonie Van Leeuwenhoek; 1980; 46(6):587-93. PubMed ID: 7235691 [TBL] [Abstract][Full Text] [Related]
10. The obligate anaerobic faecal flora of patients with Crohn's disease and their first-degree relatives. Van de Merwe JP; Schröder AM; Wensinck F; Hazenberg MP Scand J Gastroenterol; 1988 Nov; 23(9):1125-31. PubMed ID: 3247591 [TBL] [Abstract][Full Text] [Related]
11. Decreased faecal exoglycosidase activities identify a subset of patients with active Crohn's disease. el Yamani J; Mizon C; Capon C; Colombel JF; Fournet B; Cortot A; Mizon J Clin Sci (Lond); 1992 Oct; 83(4):409-15. PubMed ID: 1330402 [TBL] [Abstract][Full Text] [Related]
12. The human faecal flora and Crohn's disease. van de Merwe JP Antonie Van Leeuwenhoek; 1984; 50(5-6):691-700. PubMed ID: 6397136 [TBL] [Abstract][Full Text] [Related]
13. Increase of faecal tryptic activity relates to changes in the intestinal microbiome: analysis of Crohn's disease with a multidisciplinary platform. Midtvedt T; Zabarovsky E; Norin E; Bark J; Gizatullin R; Kashuba V; Ljungqvist O; Zabarovska V; Möllby R; Ernberg I PLoS One; 2013; 8(6):e66074. PubMed ID: 23840402 [TBL] [Abstract][Full Text] [Related]
14. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. Giaffer MH; Holdsworth CD; Duerden BI J Med Microbiol; 1991 Oct; 35(4):238-43. PubMed ID: 1941994 [TBL] [Abstract][Full Text] [Related]
15. The microbial flora of the rectal mucosa and faeces of patients with Crohn's disease before and during antimicrobial chemotherapy. Hudson MJ; Hill MJ; Elliott PR; Berghouse LM; Burnham WR; Lennard-Jones JE J Med Microbiol; 1984 Dec; 18(3):335-45. PubMed ID: 6334160 [TBL] [Abstract][Full Text] [Related]
16. Degradation of intestinal glycoproteins by Bacteroides vulgatus. Ruseler-van Embden JG; van der Helm R; van Lieshout LM FEMS Microbiol Lett; 1989 Mar; 49(1):37-41. PubMed ID: 2721924 [TBL] [Abstract][Full Text] [Related]
17. Antibodies to Eubacterium and Peptostreptococcus species and the estimated probability of Crohn's disease. Van de Merwe JP; Schmitz PI; Wensinck F J Hyg (Lond); 1981 Aug; 87(1):25-33. PubMed ID: 7252136 [TBL] [Abstract][Full Text] [Related]
18. Mucin degradation in human colon ecosystems. Evidence for the existence and role of bacterial subpopulations producing glycosidases as extracellular enzymes. Hoskins LC; Boulding ET J Clin Invest; 1981 Jan; 67(1):163-72. PubMed ID: 6161136 [TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of the viscous, high-molecular-mass microbial carbohydrate fraction from faeces of healthy subjects and patients with Crohn's disease and the consequences for a therapeutic approach. Ruseler-van Embden JG; Van Lieshout LM; Binnema DJ; Hazenberg MP Clin Sci (Lond); 1998 Oct; 95(4):425-33. PubMed ID: 9748418 [TBL] [Abstract][Full Text] [Related]
20. An international study of agglutinins to Eubacterium, Peptostreptococcus and Coprococcus species in Crohn's disease, ulcerative colitis and control subjects. Wensinck F; van de Merwe JP; Mayberry JF Digestion; 1983; 27(2):63-9. PubMed ID: 6628839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]